SLRC Q1 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 38 minutes ago
0mins
Should l Buy SLRC?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SLRC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SLRC
Wall Street analysts forecast SLRC stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 15.970
Low
16.50
Averages
17.44
High
19.00
Current: 15.970
Low
16.50
Averages
17.44
High
19.00
About SLRC
SLR Investment Corp. is a closed-end, externally managed, non-diversified management investment company. It invests primarily in privately held United States middle-market companies. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. It directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and unsecured loans, and equity securities. In addition, it shall invest in foreign markets, including emerging markets. Its business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. It invests in various industries, such as financial services, multi-sector holdings, health care providers and services, health care equipment and supplies, pharmaceuticals, consumer services, capital markets, media, software, and asset management. Its investment manager is SLR Capital Partners, LLC.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SLR Investment Reports Q1 Earnings Below Expectations, Shares Drop 13%
- Earnings Decline: SLR Investment reported Q1 net investment income per share of $0.33, missing market expectations by $0.07, which led to a 13% drop in share price during early trading, indicating market concerns over profitability.
- Insufficient Investment Income: The company's total investment income for Q1 was $49.29 million, falling short of expectations by $4.72 million, reflecting suppressed investment activity amid geopolitical volatility and disruptions in the technology sector, impacting overall performance.
- Net Asset Value Change: As of March 31, 2026, SLR Investment's net asset value per share was $18.16, down from $18.26 on December 31, 2025, indicating pressure on the company's asset value in the current market environment.
- Management Strategy Adjustment: The co-CEO of SLR Investment noted that despite achieving strong credit performance and a 100% performing portfolio in Q1, the firm has opted to permanently reduce performance-based incentive fees to better align with shareholder interests, highlighting a strong focus on capital preservation.
See More
SLRC Q1 2026 Earnings Call Transcript
See More
Analysis of High-Yield Opportunities in BDC Sector
- High Yield Appeal: The BDC sector offers yields up to 15.6%, with some trading at just 72 cents on the dollar, presenting a rare opportunity for investors amidst increasing economic uncertainty.
- Market Confidence Shaken: Investor confidence in BDCs has been rattled by fresh concerns in the private credit market, particularly following the bankruptcy of First Brands, which exposed vulnerabilities in the sector.
- Gladstone Investment Performance: Gladstone Investment (GAIN) focuses on financing lower-middle-market companies with annual EBITDA between $4 million and $15 million, and its net asset value has risen from $12.99 to $14.95 per share, indicating a robust business model.
- SLR Investment Corp. Dynamics: SLR Investment Corp. (SLRC) specializes in senior secured loans to middle-market companies, maintaining an 11.1% yield despite share price declines, demonstrating resilience in a volatile market.
See More
Latest Wall Street Rating Updates
- BofA Downgrades Qualcomm: Bank of America has downgraded Qualcomm from neutral to underperform with a price target of $145, citing lukewarm projected sales and EPS growth of only 2% and 1% CAGR from 2025 to 2028, significantly lagging the semiconductor sector's expected 17% growth.
- Deutsche Bank Upgrades Teladoc: Deutsche Bank upgraded Teladoc from hold to buy, highlighting an attractive risk/reward profile due to compelling valuation and a deliverable strategy for its BetterHelp business, indicating a strong potential for future growth.
- TD Cowen Upgrades Rivian: TD Cowen upgraded Rivian from hold to buy, projecting full-scale demand for its R2 model to reach between 212,000 and 335,000 units, suggesting significant upside potential against 2027 consensus estimates.
- Morgan Stanley Reiterates Microsoft Overweight: Morgan Stanley reiterated its overweight rating on Microsoft, emphasizing the readiness of its Office product suite for the upcoming Agentic AI offerings, with general availability expected on May 1, 2026, priced at $99 per user per month.
See More
Insider Buying Activity in SLRC and ELV
- SLRC Insider Purchase: Michael S. Gross acquired 104,819 shares of SLRC on Wednesday at $14.74 each, totaling an investment of $1.55 million, marking his first purchase in the past twelve months, indicating confidence in the company's future.
- Market Price Comparison: On Friday, SLRC shares traded as low as $14.34, which is 2.7% below Gross's purchase price, reflecting short-term market volatility that may influence investor buying decisions.
- ELV Insider Purchase: Elevance Health's Director Steven H. Collis bought 3,000 shares on Thursday at $289.84 each, totaling $869,520, signaling executive optimism regarding the company's prospects.
- ELV Market Price Dynamics: On Friday, ELV shares traded as low as $281.50, which is 2.9% lower than Collis's purchase price, indicating market reactions that could affect other investors' confidence.
See More
SLR Investment (SLRC) Q4 2025 Earnings Transcript
See More
SLR Investment Reports Q1 Earnings Below Expectations, Shares Drop 13%
- Earnings Decline: SLR Investment reported Q1 net investment income per share of $0.33, missing market expectations by $0.07, which led to a 13% drop in share price during early trading, indicating market concerns over profitability.
- Insufficient Investment Income: The company's total investment income for Q1 was $49.29 million, falling short of expectations by $4.72 million, reflecting suppressed investment activity amid geopolitical volatility and disruptions in the technology sector, impacting overall performance.
- Net Asset Value Change: As of March 31, 2026, SLR Investment's net asset value per share was $18.16, down from $18.26 on December 31, 2025, indicating pressure on the company's asset value in the current market environment.
- Management Strategy Adjustment: The co-CEO of SLR Investment noted that despite achieving strong credit performance and a 100% performing portfolio in Q1, the firm has opted to permanently reduce performance-based incentive fees to better align with shareholder interests, highlighting a strong focus on capital preservation.
See More
SLRC Q1 2026 Earnings Call Transcript
See More
Analysis of High-Yield Opportunities in BDC Sector
- High Yield Appeal: The BDC sector offers yields up to 15.6%, with some trading at just 72 cents on the dollar, presenting a rare opportunity for investors amidst increasing economic uncertainty.
- Market Confidence Shaken: Investor confidence in BDCs has been rattled by fresh concerns in the private credit market, particularly following the bankruptcy of First Brands, which exposed vulnerabilities in the sector.
- Gladstone Investment Performance: Gladstone Investment (GAIN) focuses on financing lower-middle-market companies with annual EBITDA between $4 million and $15 million, and its net asset value has risen from $12.99 to $14.95 per share, indicating a robust business model.
- SLR Investment Corp. Dynamics: SLR Investment Corp. (SLRC) specializes in senior secured loans to middle-market companies, maintaining an 11.1% yield despite share price declines, demonstrating resilience in a volatile market.
See More
Latest Wall Street Rating Updates
- BofA Downgrades Qualcomm: Bank of America has downgraded Qualcomm from neutral to underperform with a price target of $145, citing lukewarm projected sales and EPS growth of only 2% and 1% CAGR from 2025 to 2028, significantly lagging the semiconductor sector's expected 17% growth.
- Deutsche Bank Upgrades Teladoc: Deutsche Bank upgraded Teladoc from hold to buy, highlighting an attractive risk/reward profile due to compelling valuation and a deliverable strategy for its BetterHelp business, indicating a strong potential for future growth.
- TD Cowen Upgrades Rivian: TD Cowen upgraded Rivian from hold to buy, projecting full-scale demand for its R2 model to reach between 212,000 and 335,000 units, suggesting significant upside potential against 2027 consensus estimates.
- Morgan Stanley Reiterates Microsoft Overweight: Morgan Stanley reiterated its overweight rating on Microsoft, emphasizing the readiness of its Office product suite for the upcoming Agentic AI offerings, with general availability expected on May 1, 2026, priced at $99 per user per month.
See More
Insider Buying Activity in SLRC and ELV
- SLRC Insider Purchase: Michael S. Gross acquired 104,819 shares of SLRC on Wednesday at $14.74 each, totaling an investment of $1.55 million, marking his first purchase in the past twelve months, indicating confidence in the company's future.
- Market Price Comparison: On Friday, SLRC shares traded as low as $14.34, which is 2.7% below Gross's purchase price, reflecting short-term market volatility that may influence investor buying decisions.
- ELV Insider Purchase: Elevance Health's Director Steven H. Collis bought 3,000 shares on Thursday at $289.84 each, totaling $869,520, signaling executive optimism regarding the company's prospects.
- ELV Market Price Dynamics: On Friday, ELV shares traded as low as $281.50, which is 2.9% lower than Collis's purchase price, indicating market reactions that could affect other investors' confidence.
See More
SLR Investment (SLRC) Q4 2025 Earnings Transcript
See More
